Item Type | Name |
Concept
|
Antigens, Neoplasm
|
Concept
|
Antigens, Ly
|
Concept
|
Histocompatibility Antigens Class II
|
Concept
|
HLA-DP Antigens
|
Concept
|
HLA-DR Antigens
|
Concept
|
HLA-DQ Antigens
|
Concept
|
Histocompatibility Antigens
|
Concept
|
HLA Antigens
|
Concept
|
Receptors, Antigen, B-Cell
|
Concept
|
HLA-A2 Antigen
|
Concept
|
HLA-A Antigens
|
Concept
|
Ki-1 Antigen
|
Concept
|
Histocompatibility Antigens Class I
|
Concept
|
HLA-C Antigens
|
Concept
|
CD8 Antigens
|
Concept
|
Antigens, CD
|
Concept
|
Antigens, Nuclear
|
Concept
|
Prostate-Specific Antigen
|
Concept
|
Receptors, Antigen, T-Cell, alpha-beta
|
Concept
|
Antigen Presentation
|
Concept
|
CA-19-9 Antigen
|
Concept
|
CA-125 Antigen
|
Concept
|
B7-H1 Antigen
|
Concept
|
CD11c Antigen
|
Concept
|
Minor Histocompatibility Antigens
|
Concept
|
Thy-1 Antigens
|
Concept
|
Proliferating Cell Nuclear Antigen
|
Concept
|
Ki-67 Antigen
|
Concept
|
HLA-B52 Antigen
|
Concept
|
Carcinoembryonic Antigen
|
Concept
|
Receptors, Antigen, T-Cell
|
Concept
|
HLA-B Antigens
|
Concept
|
CD4 Antigens
|
Concept
|
HLA-A24 Antigen
|
Academic Article
|
Ring finger protein 43 as a new target for cancer immunotherapy.
|
Academic Article
|
Mouse homologue of a novel human oncofetal antigen, glypican-3, evokes T-cell-mediated tumor rejection without autoimmune reactions in mice.
|
Academic Article
|
Identification of a novel tumor-associated antigen, cadherin 3/P-cadherin, as a possible target for immunotherapy of pancreatic, gastric, and colorectal cancers.
|
Academic Article
|
Proliferation potential-related protein, an ideal esophageal cancer antigen for immunotherapy, identified using complementary DNA microarray analysis.
|
Academic Article
|
HLA-B*3505 allele is a strong predictor for nevirapine-induced skin adverse drug reactions in HIV-infected Thai patients.
|
Academic Article
|
HLA-DRB1*0901 lowers anti-cyclic citrullinated peptide antibody levels in Japanese patients with rheumatoid arthritis.
|
Academic Article
|
A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians.
|
Academic Article
|
ADAM8 as a novel serological and histochemical marker for lung cancer.
|
Academic Article
|
Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma.
|
Academic Article
|
New pharmacogenetic test for detecting an HLA-A*31: 01 allele using the InvaderPlus assay.
|
Academic Article
|
Reproducibility, performance, and clinical utility of a genetic risk prediction model for prostate cancer in Japanese.
|
Academic Article
|
Functional SNPs in CD244 increase the risk of rheumatoid arthritis in a Japanese population.
|
Academic Article
|
New sequence variants in HLA class II/III region associated with susceptibility to knee osteoarthritis identified by genome-wide association study.
|
Academic Article
|
Prostate cancer genomics, biology, and risk assessment through genome-wide association studies.
|
Academic Article
|
A genome-wide association study identifies two new susceptibility loci for lung adenocarcinoma in the Japanese population.
|
Academic Article
|
Association between HLA-B*4001 and lipodystrophy among HIV-infected patients from Thailand who received a stavudine-containing antiretroviral regimen.
|
Academic Article
|
Genome-wide association study identifies HLA-DP as a susceptibility gene for pediatric asthma in Asian populations.
|
Academic Article
|
Soluble MICA and a MICA variation as possible prognostic biomarkers for HBV-induced hepatocellular carcinoma.
|
Academic Article
|
Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.
|
Academic Article
|
Development of new HLA-B*3505 genotyping method using Invader assay.
|
Academic Article
|
Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population.
|
Academic Article
|
HLA-Cw*1202-B*5201-DRB1*1502 haplotype increases risk for ulcerative colitis but reduces risk for Crohn's disease.
|
Academic Article
|
A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population.
|
Academic Article
|
Identification of Epstein-Barr virus-induced gene 3 as a novel serum and tissue biomarker and a therapeutic target for lung cancer.
|
Academic Article
|
A genome-wide association study identifies two susceptibility loci for duodenal ulcer in the Japanese population.
|
Academic Article
|
Single-nucleotide polymorphisms in the class II region of the major histocompatibility complex in Japanese patients with immunoglobulin A nephropathy.
|
Academic Article
|
Involvement of RQCD1 overexpression, a novel cancer-testis antigen, in the Akt pathway in breast cancer cells.
|
Academic Article
|
Histone lysine methyltransferase SETD8 promotes carcinogenesis by deregulating PCNA expression.
|
Academic Article
|
Impact of PSCA variation on gastric ulcer susceptibility.
|
Academic Article
|
A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities.
|
Academic Article
|
Involvement of G-patch domain containing 2 overexpression in breast carcinogenesis.
|
Academic Article
|
Identification of a functional variant in the MICA promoter which regulates MICA expression and increases HCV-related hepatocellular carcinoma risk.
|
Academic Article
|
Analysis of single-nucleotide polymorphisms in Japanese rheumatoid arthritis patients shows additional susceptibility markers besides the classic shared epitope susceptibility sequences.
|
Academic Article
|
Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer.
|
Academic Article
|
Cancer peptide vaccine therapy developed from oncoantigens identified through genome-wide expression profile analysis for bladder cancer.
|
Academic Article
|
Identification of promiscuous KIF20A long peptides bearing both CD4+ and CD8+ T-cell epitopes: KIF20A-specific CD4+ T-cell immunity in patients with malignant tumor.
|
Academic Article
|
Vaccination with multiple peptides derived from novel cancer-testis antigens can induce specific T-cell responses and clinical responses in advanced esophageal cancer.
|
Academic Article
|
[Phase I study of combination therapy with peptide vaccine and anti-cancer drug for colorectal cancer].
|
Academic Article
|
A novel tumor-associated antigen, cell division cycle 45-like can induce cytotoxic T-lymphocytes reactive to tumor cells.
|
Academic Article
|
Identification of an HLA-A2-restricted epitope peptide derived from hypoxia-inducible protein 2 (HIG2).
|
Academic Article
|
HLA-A SNPs and amino acid variants are associated with nasopharyngeal carcinoma in Malaysian Chinese.
|
Academic Article
|
Detection of novel cancer-testis antigen-specific T-cell responses in TIL, regional lymph nodes, and PBL in patients with esophageal squamous cell carcinoma.
|
Academic Article
|
Enhanced expression of EHMT2 is involved in the proliferation of cancer cells through negative regulation of SIAH1.
|
Academic Article
|
Identification of secernin 1 as a novel immunotherapy target for gastric cancer using the expression profiles of cDNA microarray.
|
Academic Article
|
Identification of SPARC as a candidate target antigen for immunotherapy of various cancers.
|
Academic Article
|
Associations of HLA-DP variants with hepatitis B virus infection in southern and northern Han Chinese populations: a multicenter case-control study.
|
Academic Article
|
Isolation of LEM domain-containing 1, a novel testis-specific gene expressed in colorectal cancers.
|
Academic Article
|
Identification of human leukocyte antigen-A24-restricted epitope peptides derived from gene products upregulated in lung and esophageal cancers as novel targets for immunotherapy.
|
Academic Article
|
Cancer-testis antigen lymphocyte antigen 6 complex locus K is a serologic biomarker and a therapeutic target for lung and esophageal carcinomas.
|
Academic Article
|
FCRL3, an autoimmune susceptibility gene, has inhibitory potential on B-cell receptor-mediated signaling.
|
Academic Article
|
A phase ?I study of five peptides combination with oxaliplatin-based chemotherapy as a first-line therapy for advanced colorectal cancer (FXV study).
|
Academic Article
|
PDZ-binding kinase/T-LAK cell-originated protein kinase, a putative cancer/testis antigen with an oncogenic activity in breast cancer.
|
Academic Article
|
Oncogenic role of KIAA0101 interacting with proliferating cell nuclear antigen in pancreatic cancer.
|
Academic Article
|
Oncogenic role of MPHOSPH1, a cancer-testis antigen specific to human bladder cancer.
|
Academic Article
|
Quantitative characterization of T-cell repertoire in allogeneic hematopoietic stem cell transplant recipients.
|
Academic Article
|
HLA-A2-restricted CTL epitopes of a novel lung cancer-associated cancer testis antigen, cell division cycle associated 1, can induce tumor-reactive CTL.
|
Academic Article
|
Identification of CDCA1-derived long peptides bearing both CD4+ and CD8+ T-cell epitopes: CDCA1-specific CD4+ T-cell immunity in cancer patients.
|
Academic Article
|
Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens.
|
Academic Article
|
Herpes simplex virus-induced, death receptor-dependent apoptosis and regression of transplanted human cancers.
|
Academic Article
|
Phase I/II study of S-1 plus cisplatin combined with peptide vaccines for human vascular endothelial growth factor receptor 1 and 2 in patients with advanced gastric cancer.
|
Academic Article
|
Identification of HLA-A24-restricted novel T Cell epitope peptides derived from P-cadherin and kinesin family member 20A.
|
Academic Article
|
The current and future applications of immunopharmacogenomics.
|
Academic Article
|
Characterization of T-cell Receptor Repertoire in Inflamed Tissues of Patients with Crohn's Disease Through Deep Sequencing.
|
Academic Article
|
Serum tumor antigen REG4 as a diagnostic biomarker in pancreatic ductal adenocarcinoma.
|
Academic Article
|
Eradication of Large Solid Tumors by Gene Therapy with a T-Cell Receptor Targeting a Single Cancer-Specific Point Mutation.
|
Academic Article
|
Phase I clinical trial of a five-peptide cancer vaccine combined with cyclophosphamide in advanced solid tumors.
|
Academic Article
|
Clonal expansion of antitumor T cells in breast cancer correlates with response to neoadjuvant chemotherapy.
|
Academic Article
|
Deep-sequencing of the T-cell receptor repertoire in patients with haplo-cord and matched-donor transplants.
|
Academic Article
|
Myasthenic crisis and polymyositis induced by one dose of nivolumab.
|
Academic Article
|
Association of variations in HLA class II and other loci with susceptibility to EGFR-mutated lung adenocarcinoma.
|
Academic Article
|
The forkhead box M1 transcription factor as a candidate of target for anti-cancer immunotherapy.
|
Academic Article
|
Phase II clinical trial of peptide cocktail therapy for patients with advanced pancreatic cancer: VENUS-PC study.
|
Academic Article
|
Significant Effect of Polymorphisms in CYP2D6 on Response to Tamoxifen Therapy for Breast Cancer: A Prospective Multicenter Study.
|
Academic Article
|
Comparison of exome-based HLA class I genotyping tools: identification of platform-specific genotyping errors.
|
Academic Article
|
TOPK (T-LAK cell-originated protein kinase) inhibitor exhibits growth suppressive effect on small cell lung cancer.
|
Academic Article
|
WHSC1L1-mediated EGFR mono-methylation enhances the cytoplasmic and nuclear oncogenic activity of EGFR in head and neck cancer.
|
Academic Article
|
Quantitative characterization of T-cell repertoire and biomarkers in kidney transplant rejection.
|
Academic Article
|
Predictive biomarkers for the efficacy of peptide vaccine treatment: based on the results of a phase II study on advanced pancreatic cancer.
|
Academic Article
|
Clinical and histopathological characteristics of patients with prostate cancer in the BioBank Japan project.
|
Academic Article
|
Clinical significance of T cell clonality and expression levels of immune-related genes in endometrial cancer.
|
Academic Article
|
Multiple therapeutic peptide vaccines for patients with advanced gastric cancer.
|
Academic Article
|
Phase I clinical trial of cell division associated 1 (CDCA1) peptide vaccination for castration resistant prostate cancer.
|
Academic Article
|
Characterization of the T-Cell Receptor Repertoire and Immune Microenvironment in Patients with Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck.
|
Academic Article
|
Activation of Th1 Immunity within the Tumor Microenvironment Is Associated with Clinical Response to Lenalidomide in Chronic Lymphocytic Leukemia.
|
Academic Article
|
Induction of Neoantigen-Specific Cytotoxic T Cells and Construction of T-cell Receptor-Engineered T Cells for Ovarian Cancer.
|
Academic Article
|
Immunotherapy with cancer peptides in combination with intravesical bacillus Calmette-Guerin for patients with non-muscle invasive bladder cancer.
|
Academic Article
|
Immunopharmacogenomics towards personalized cancer immunotherapy targeting neoantigens.
|
Academic Article
|
Characterization of the B-cell receptor repertoires in peanut allergic subjects undergoing oral immunotherapy.
|
Academic Article
|
Significant differences in T cell receptor repertoires in lung adenocarcinomas with and without epidermal growth factor receptor mutations.
|
Academic Article
|
Identification of two novel breast cancer loci through large-scale genome-wide association study in the Japanese population.
|
Academic Article
|
The GALNT6-LGALS3BP axis promotes breast cancer cell growth.
|
Academic Article
|
Bioinformatic prediction of potential T cell epitopes for SARS-Cov-2.
|
Academic Article
|
Intranodal Administration of Neoantigen Peptide-loaded Dendritic Cell Vaccine Elicits Epitope-specific T Cell Responses and Clinical Effects in a Patient with Chemorefractory Ovarian Cancer with Malignant Ascites.
|
Academic Article
|
SARS-CoV-2 genomic variations associated with mortality rate of COVID-19.
|
Academic Article
|
CD8 lymphocytes in tumors and nonsynonymous mutational load correlate with prognosis of bladder cancer patients treated with immune checkpoint inhibitors.
|
Academic Article
|
Phase II Adjuvant Cancer-specific Vaccine Therapy for Esophageal Cancer Patients Curatively Resected After Preoperative Therapy With Pathologically Positive Nodes; Possible Significance of Tumor Immune Microenvironment in its Clinical Effects.
|
Academic Article
|
Diversity in immunogenomics: the value and the challenge.
|
Academic Article
|
Generation of neoantigen-specific T cells for adoptive cell transfer for treating head and neck squamous cell carcinoma.
|
Academic Article
|
Neoantigens elicit T cell responses in breast cancer.
|
Academic Article
|
Efficacy of Intranodal Neoantigen Peptide-pulsed Dendritic Cell Vaccine Monotherapy in Patients With Advanced Solid Tumors: A Retrospective Analysis.
|
Academic Article
|
Contribution of pre-existing neoantigen-specific T cells to a durable complete response after tumor-pulsed dendritic cell vaccine plus nivolumab therapy in a patient with metastatic salivary duct carcinoma.
|
Academic Article
|
Identification of cytotoxic T cells and their T cell receptor sequences targeting COVID-19 using MHC class I-binding peptides.
|
Academic Article
|
Lymphocytes in tumor-draining lymph nodes co-cultured with autologous tumor cells for adoptive cell therapy.
|
Academic Article
|
Immunological analysis of hybrid neoantigen peptide encompassing class I/II neoepitope-pulsed dendritic cell vaccine.
|